Pfizer agrees to pay $345 million to resolve EpiPen lawsuit

6 monate vor


Pfizer has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anticompetitive practices by the drugmaker and Mylan, the company that markets the emergency allergy treatment. #Pfizer #Mylan #EpiPen #News #Reuters Subscribe: http://smarturl.it/reuterssubscribe Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled. Get the latest news on: http://reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/Reuters Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Aus der Quelle lesen